Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological activity of macromomycin.

T Hidaka, Y Yano, T Yamashita

    The Journal of Antibiotics
    |April 1, 1979
    PubMed
    Summary

    Macromomycin (MCR), an antitumor antibiotic, effectively inhibited Ehrlich ascites carcinoma and L1210 leukemia in preclinical models. It also showed promise against early Lewis lung carcinoma and synergistic effects with other chemotherapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of drugs acting on Cl(-)-HCO3- and Na(+)-H+ exchangers on acid secretion in the rat gastric mucosa sheet preparation.

    European journal of pharmacology·1992
    Same author

    Plasminogen activator in periodontal health and disease.

    Annals of the New York Academy of Sciences·1992
    Same author

    Abnormal continuous flow in giant intracranial aneurysm detected by transcranial Doppler sonography--case report.

    Neurologia medico-chirurgica·1992
    Same author

    Production and characterization of two monoclonal antibodies to human glutathione peroxidase.

    Hybridoma·1992
    Same author

    [Distribution of Clostridium botulinum and Clostridium tetani in Okinawa Prefecture].

    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases·1992
    Same author

    [Acute toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl) amino] benzoate dimethanesulfonate (FUT-187) in mice, rats and dogs.

    The Journal of toxicological sciences·1992

    Area of Science:

    • Pharmacology
    • Microbiology
    • Oncology

    Background:

    • Macromomycin (MCR) is a polypeptide antibiotic derived from *Streptomyces macromomyceticus*.
    • MCR exhibits potential antitumor properties that warrant investigation in various cancer models.

    Purpose of the Study:

    • To evaluate the antitumor efficacy of Macromomycin (MCR) against Ehrlich ascites carcinoma, L1210 leukemia, and Lewis lung carcinoma.
    • To assess the activity of MCR via different administration routes and in combination with other chemotherapeutic agents.

    Main Methods:

    • In vivo studies using mouse models for Ehrlich ascites carcinoma, L1210 leukemia, and Lewis lung carcinoma.
    • Administration of MCR through intraperitoneal, intravenous, and subcutaneous routes.
    • Combination therapy studies with aracytidine and cyclophosphamide.
    • Assessment of MCR stability in serum compared to neocarzinostatin.

    Main Results:

    • MCR demonstrated significant inhibition of Ehrlich ascites carcinoma with daily intraperitoneal treatment.
    • Both single and repeated MCR injections were effective against L1210 leukemia, regardless of administration route (intraperitoneal or intravenous).
    • Subcutaneous MCR injections prolonged survival in Lewis lung carcinoma models, with some cures observed; however, intraperitoneal MCR was ineffective. Intravenous MCR inhibited early-stage Lewis lung carcinoma but not advanced stages.
    • MCR exhibited synergistic antitumor activity when combined with aracytidine or cyclophosphamide against L1210 leukemia.
    • MCR remained stable after serum treatment, unlike neocarzinostatin.

    Conclusions:

    • Macromomycin (MCR) possesses broad-spectrum antitumor activity against various murine cancer models.
    • The efficacy of MCR is dependent on the tumor type, stage, and administration route.
    • MCR shows potential as a chemotherapeutic agent, particularly in combination therapies, and demonstrates superior stability compared to neocarzinostatin.

    Related Experiment Videos